Skip to main content
logo
Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.1020
-0.0100 (-8.93%)
At close: Oct 21, 2026, 4:00 PM EDT
0.1048
+0.0028 (2.75%)
After-hours: Oct 21, 2026, 7:51 PM EDT

Cellyan Biotechnology Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Revenue
13.4320.3116.6912.56
Revenue Growth
-33.87%21.72%32.91%-
Cost of Revenue
12.0517.913.139.82
Gross Profit
1.392.423.562.74
Selling, General & Admin
2.42.221.891.76
Other Operating Expenses
-00.0100
Operating Expenses
2.392.221.891.76
Operating Income
-10.191.670.98
Interest Expense
-0.13-0.1-0.08-0.02
Interest & Investment Income
0000
Currency Exchange Gain (Loss)
-0.04-0.01-0.06-0.03
EBT Excluding Unusual Items
-1.180.091.520.92
Gain (Loss) on Sale of Investments
0.08-0.04--
Gain (Loss) on Sale of Assets
-0.03-0.010-
Other Unusual Items
0-00.1
Pretax Income
-1.130.041.531.02
Income Tax Expense
0.010.060.20.02
Net Income
-1.14-0.031.331
Net Income to Common
-1.14-0.031.331
Net Income Growth
--33.21%-
Shares Outstanding (Basic)
161077
Shares Outstanding (Diluted)
161077
Shares Change
60.21%38.56%7.64%-
EPS (Basic)
-0.07-0.000.180.15
EPS (Diluted)
-0.07-0.000.180.15
EPS Growth
--23.40%-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Free Cash Flow
-0.790.5-0.451.61
Free Cash Flow Per Share
-0.050.05-0.060.24
Gross Margin
10.32%11.89%21.32%21.81%
Operating Margin
-7.48%0.94%10.00%7.80%
Profit Margin
-8.46%-0.13%7.97%7.95%
Free Cash Flow Margin
-5.86%2.46%-2.68%12.84%
EBITDA
-0.920.271.731.05
EBITDA Margin
-6.84%1.31%10.38%8.39%
D&A For EBITDA
0.090.080.060.07
EBIT
-10.191.670.98
EBIT Margin
-7.48%0.94%10.00%7.80%
Effective Tax Rate
-174.92%12.86%2.21%
SEC Filings: 10-K · 10-Q